AIM Concept Integration
4th Year MBBS
Endocrine + Reproduction
Endocrine + Reproduction
Hypothyroidism and Structural Thyroid Disease: Thyroiditis, Goitre, Malignancy and Thyroid Hormone Therapy
Connect the major mechanisms, clinical clues, investigations, treatment principles and prevention points for rapid revision.
1. THE TOPIC IN ONE CONNECTED FLOW
Thyroid disease in this topic can be understood through one central relationship: a problem affecting iodine supply, thyroid follicles or thyroid-cell growth changes hormone production or gland structure. That change produces hypothyroid symptoms, thyroid enlargement or a suspicious neck mass, which is then recognized through thyroid-function testing, imaging and selected tissue assessment.
Cause / Initiating Problem
Iodine deficiency, autoimmune injury, inflammation, repeated growth stimuli or neoplastic change
→
Core Mechanism
Reduced hormone synthesis, follicular destruction, repeated hyperplasia/involution or abnormal tumor-cell proliferation
→
Structural / Functional Change
Low T3/T4, thyroid inflammation, multinodular enlargement or malignant thyroid mass
→
Clinical Presentation
Fatigue, cold intolerance and constipation; painful or painless goitre; nodular swelling or progressive neck mass
→
Diagnostic Clue
TSH + free T4 → ultrasound → selected FNAC or histology; calcitonin when medullary carcinoma is relevant
→
Treatment / Prevention
Levothyroxine, symptom-directed thyroiditis care, surgery or radioiodine where appropriate, and adequate iodine supply
→
Outcome / Complication
Restored hormone function, recovery from inflammation, relief of compression or control of malignancy; untreated disease may progress
2. KEY CLINICAL CONNECTIONS
Hypothyroidism
Low thyroid hormone
→
reduced metabolic activity
→
fatigue, cold intolerance, constipation and bradycardia
→
reduced metabolic activity
→
fatigue, cold intolerance, constipation and bradycardia
Primary thyroid failure
→
low free T4 + raised TSH
→
levothyroxine replacement
→
low free T4 + raised TSH
→
levothyroxine replacement
Thyroiditis
Autoimmune follicular destruction
→
lymphocytes + Hürthle cells
→
Hashimoto hypothyroidism
→
lymphocytes + Hürthle cells
→
Hashimoto hypothyroidism
Granulomatous follicular injury
→
stored hormone leakage + painful thyroid
→
de Quervain thyroiditis
→
stored hormone leakage + painful thyroid
→
de Quervain thyroiditis
Goitre and Thyroid Cancer
Repeated follicular growth and involution
→
multinodular goitre
→
compression or autonomous hormone production
→
multinodular goitre
→
compression or autonomous hormone production
Suspicious thyroid lesion
→
ultrasound ± FNAC/histology
→
malignancy-specific treatment
→
ultrasound ± FNAC/histology
→
malignancy-specific treatment
3. AIM HIGH-YIELD INTEGRATION REVIEW
⭐ Primary hypothyroidism → reduced T4 removes negative feedback → TSH rises; levothyroxine restores normal thyroid-hormone action.
Hashimoto thyroiditis → autoimmune follicular destruction → lymphoid germinal centres and Hürthle-cell change → progressive hypothyroidism.
de Quervain thyroiditis → granulomatous follicular injury → painful tender thyroid + transient hormone leakage → symptomatic anti-inflammatory treatment.
Iodine deficiency → impaired thyroid hormone synthesis → increased TSH → follicular hypertrophy/hyperplasia → diffuse and later multinodular goitre.
⭐ Papillary carcinoma → characteristic nuclear changes ± psammoma bodies → lymphatic spread to cervical nodes → generally favorable prognosis.
⭐ Follicular carcinoma → capsular or vascular invasion → hematogenous spread; invasion requires histological assessment rather than cytology alone.
Medullary carcinoma → C-cell origin → calcitonin production + amyloid deposition → surgery is central because radioiodine is ineffective.
⭐ Levothyroxine → T4 converted to T3 → nuclear receptor activation → physiological replacement; excessive therapy can produce tachycardia, arrhythmia and bone loss.
AIM Exam Trap:
Follicular-patterned cytology
→
cannot demonstrate capsular or vascular invasion
→
FNAC cannot reliably distinguish follicular adenoma from follicular carcinoma.
Follicular-patterned cytology
→
cannot demonstrate capsular or vascular invasion
→
FNAC cannot reliably distinguish follicular adenoma from follicular carcinoma.
